Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Semaglutide can feel like a slower start but steady progress
Benefits of GLP-1 and GIP Medications These medications may help people with: Type 2 diabetes Overweight or obesity Heart or metabolic risk factors They may help the body: Produce more insulin when needed Lower blood sugar Feel full faster and longer Lose weight in some cases Types of GLP-1 Medications Single Agonists: These mimic only GLP-1 activity
The -subunit contains a kinase domain
Affordability: Generally lower cost compared to IV therapy
Key benefits Why people compare it 1 22.5% mean body weight reduction at 15mg in SURMOUNT-1 (N=2,539, 72 weeks) 2 Dual GIP/GLP-1 receptor activation for combined metabolic effects beyond single-agonist therapy 3 63% of participants at highest dose achieved at least 20% weight loss vs 1.3% placebo 4 Superior A1C reduction of 2.07-2.59% with up to 97% of diabetic participants reaching target 5 Outperformed semaglutide 1mg head-to-head in SURPASS-2 for both weight and glycemic endpoints 6 Enhanced adipose tissue lipid handling and fat redistribution via GIPR signaling 7 Significant improvements in triglycerides, blood pressure, and waist circumference across all doses 8 Once-weekly dosing supported by 120-hour half-life and C20 fatty diacid albumin binding Deep research Tirzepatide is a 39-amino-acid synthetic peptide with a molecular weight of 4,813.45 Da
